Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension

Clinical Trial ID NCT02391779

PubWeight™ 0.77‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02391779

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 2009 1.14
2 Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 2007 1.04
3 A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 2009 1.01
4 Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev 2010 1.00
5 Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One 2007 0.98
6 Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013 0.92
7 Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders. Molecules 2016 0.80
Next 100